Open AccessGastrin‐Releasing Peptide Contributes to the Regulation of Adult Hippocampal Neurogenesis and Neuronal Development
Author(s) -
Walton Noah M.,
de Koning Anoek,
Xie Xiuyuan,
Shin Rick,
Chen Qian,
Miyake Shinichi,
Tajinda Katsunori,
Gross Adam K.,
Kogan Jeffrey H.,
Heusner Carrie L.,
Tamura Kouichi,
Matsumoto Mitsuyuki
Publication year - 2014
Publication title -
stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.159
H-Index - 229
eISSN - 1549-4918
pISSN - 1066-5099
DOI - 10.1002/stem.1740
Subject(s) - biology , neurogenesis , hippocampal formation , gastrin , microbiology and biotechnology , neuroscience , endocrinology , medicine , secretion
In the postnatal hippocampus, newly generated neurons contribute to learning and memory. Disruptions in neurogenesis and neuronal development have been linked to cognitive impairment and are implicated in a broad variety of neurological and psychiatric disorders. To identify putative factors involved in this process, we examined hippocampal gene expression alterations in mice possessing a heterozygous knockout of the calcium/calmodulin‐dependent protein kinase II alpha heterozygous knockout gene (CaMK2α‐hKO), an established model of cognitive impairment that also displays altered neurogenesis and neuronal development. Using this approach, we identified gastrin‐releasing peptide (GRP) as the most dysregulated gene. In wild‐type mice, GRP labels NeuN‐positive neurons, the lone exception being GRP‐positive, NeuN‐negative cells in the subgranular zone, suggesting GRP expression may be relevant to neurogenesis and/or neuronal development. Using a model of in vitro hippocampal neurogenesis, we determined that GRP signaling is essential for the continued survival and development of newborn neurons, both of which are blocked by transient knockdown of GRP's cognate receptor (GRPR). Furthermore, GRP appears to negatively regulate neurogenesis‐associated proliferation in neural stem cells both in vitro and in vivo. Intracerebroventricular infusion of GRP resulted in a decrease in immature neuronal markers, increased cAMP response element‐binding protein (CREB) phosphorylation, and decreased neurogenesis. Despite increased levels of GRP mRNA, CaMK2α‐hKO mutant mice expressed reduced levels of GRP peptide. This lack of GRP may contribute to the elevated neurogenesis and impaired neuronal development, which are reversed following exogenous GRP infusion. Based on these findings, we hypothesize that GRP modulates neurogenesis and neuronal development and may contribute to hippocampus‐associated cognitive impairment. S tem C ells 2014;32:2454–2466